Frontlight ResearchEarly access
Trial site
Padova
- 5running trials
- 5closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers1 trial
- Chronic myeloid leukaemia1 trial
- Hidradenitis suppurativa1 trial
- Melanoma1 trial
- Metastatic breast cancer1 trial
- Multiple sclerosis1 trial
- Myeloproliferative neoplasms1 trial
- Neuroendocrine tumours1 trial
- Prostate cancer1 trial
- Sickle cell disease1 trial
- Phase
- Phase 33 trials
- Phase 22 trials
- Status
- Completed3 trials
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals10 trials
Running trials
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Hidradenitis suppurativa1 recruiting
Closed trials
Completed
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy
Completed
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 18 Nov 2026